Your browser doesn't support javascript.
loading
CD1 and MR1: An update after a long-awaited reunion.
Gherardin, Nicholas A; Legoux, Francois; Consonni, Michela; Paget, Christophe.
Afiliação
  • Gherardin NA; Department of Microbiology & Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, VIC 3000, Australia. Electronic address: n.gherardin@unimelb.edu.au.
  • Legoux F; INSERM ERL1305, CNRS UMR6290, Université de Rennes 1, Institut de Génétique & Développement de Rennes, France.
  • Consonni M; Experimental Immunology Unit, Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, Milan 20132, Italy.
  • Paget C; Centre d'Etude des Pathologies Respiratoires, INSERM U1100, Université de Tours, Faculté de Médecine de Tours, 37000, Tours, France.
Immunity ; 55(12): 2211-2216, 2022 12 13.
Article em En | MEDLINE | ID: mdl-36516812
ABSTRACT
CD1 molecules and the MHC-related protein 1 (MR1) present lipid and small molecule antigens, respectively, for T cell surveillance. The biology of these molecules, the antigens they present, and the T cells that respond to them were recently discussed during the 12th International CD1-MR1 Meeting held in Gothenburg, Sweden.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antígenos de Histocompatibilidade Classe I / Antígenos CD1 Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antígenos de Histocompatibilidade Classe I / Antígenos CD1 Idioma: En Ano de publicação: 2022 Tipo de documento: Article